Oral Presentation
Janick Weberpals, RPh, PhD (he/him/his)
Instructor in Medicine
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Boston, United States
Pamela A. Shaw
Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States
Kueiyu Joshua Lin, MD, ScD
Assistant Professor
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Richard Wyss, PhD
Assistant Professor
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Boston, United States
Joseph M. Plasek
Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
Li Zhou
Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
Kerry Ngan
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
Thomas DeRamus
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
Sudha R. R. Raman, PhD (she/her/hers)
Assistant Professor
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
Durham, United States
Bradley G. Hammill, DrPH (he/him/his)
Associate Professor
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
Durham, United States
Hana Lee, PhD
Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States
Darren Toh, ScD
Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA, United States
John G. Connolly
Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, United States
Kimberly J. Dandreo
Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, United States
Fang Tian
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
Silver Spring, United States
Wei Liu, PhD, MSc
Office of Surveillance and Epidemiology, US Food and Drug Administration
Silver Spring, United States
Jie J. Li, PhD (she/her/hers)
Associate Director RWE
Office of Surveillance and Epidemiology, CDER, US FDA
Silver Spring, United States
José J. Hernández-Muñoz, RPh, MPH, MSc, PhD
Pharmacoepidemiologist
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
The Woodlands, United States
Sebastian Schneeweiss, MD, ScD (he/him/his)
Professor of Medicine
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Rishi J. Desai, PhD
Associate Professor
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Boston, United States